The majority of investigations have reported increased circulating ANGPTL3 in patients with obesity or T2D [21,22,23], whereas other studies have found that the plasma levels of ANGPTL3 are not higher in obese individuals than in controls [24,25]. This evidence concerns the gene ANGPTL3 and obesity due to melanocortin 4 receptor deficiency.